Spero Therapeutics (SPRO) Total Debt Growth (1y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -79.03% |
| Jun 30, 2024 | -65.28% |
| Mar 31, 2024 | -55.29% |
| Dec 31, 2023 | -9.38% |
| Sep 30, 2023 | -75.00% |
| Jun 30, 2023 | -68.97% |
| Mar 31, 2023 | -92.43% |
| Dec 31, 2022 | -30.43% |
| Sep 30, 2022 | 67.57% |
| Jun 30, 2022 | 46.84% |
| Mar 31, 2022 | 568.45% |
| Dec 31, 2021 | -22.03% |
| Sep 30, 2021 | -20.43% |
| Jun 30, 2021 | -19.39% |
| Mar 31, 2021 | -18.05% |
| Dec 31, 2020 | -28.92% |
| Sep 30, 2020 | -61.17% |
| Jun 30, 2020 | -62.02% |
| Mar 31, 2020 | -61.68% |
| Dec 31, 2019 | 11.66% |
| Sep 30, 2019 | 114.80% |
| Jun 30, 2019 | 131.39% |
| Mar 31, 2019 | 139.91% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 2.76% |
| Dec 31, 2017 | -91.77% |